COMMITTED TO A WORLD WHERE CARDIOVASCULAR DISEASE IS NO LONGER THE LEADING CAUSE OF DEATH
A COMMITTED PLAYER IN CARDIOVASCULAR CARE GROWING OUR IMPACT FOR PATIENTS GLOBALLY
Amarin Corporation is dedicated to reducing cardiovascular disease, which is the leading cause of death. We aim to shape a new global standard in cardiovascular care and deliver meaningful, lasting impact for patients everywhere.
What are you looking for?
Enter your search terms below to find what you are looking for on our website:
ENVISIONING A BETTER FUTURE
Amarin Corporation is a global pharmaceutical company committed to reducing the cardiovascular disease burden for patients and communities and to advancing the science of cardiovascular care around the world. We own and support a global branded product approved by multiple regulatory authorities based on a track record of proven efficacy and safety and backed by robust clinical trial evidence
©2025 Amarin Pharmaceuticals Ireland Limited. All rights reserved.
AMARIN, VASCEPA, VAZKEPA and REDUCE-IT names and logos are trademarks of Amarin Pharmaceuticals Ireland Limited. | ALL-NP-00014 1/23
Get In Touch
Whether you’re a patient, a healthcare professional or a job seeker, you can find the best way to contact us from the options below. We’d love to hear from you:
Follow Us
Follow Amarin on our social channels for the latest company news, product campaigns and industry updates:
